Ramin Farzaneh-Far insider trades: Ra Pharmaceuticals (RARX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ramin reports to the SEC
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2020 | RARX | ↓ Sell | 10,595 | $45.16 | $479K | Direct | Mar 18, 2020 (2d) |
| Feb 18, 2020 | RARX | ↓ Sell | 10,595 | $46.61 | $494K | Direct | Feb 20, 2020 (2d) |
| Jan 15, 2020 | RARX | ↓ Sell | 10,595 | $46.95 | $497K | Direct | Jan 16, 2020 (1d) |
| Dec 16, 2019 | RARX | ↓ Sell | 10,595 | $47.23 | $500K | Direct | Dec 18, 2019 (2d) |
| Nov 15, 2019 | RARX | ↓ Sell | 10,595 | $46.66 | $494K | Direct | Nov 18, 2019 (3d) |
| Oct 15, 2019 | RARX | ↓ Sell | 10,595 | $46.89 | $497K | Direct | Oct 17, 2019 (2d) |
| Sep 16, 2019 | RARX | ↓ Sell | 10,595 | $25.26 | $268K | Direct | Sep 16, 2019 (0d) |
| Aug 23, 2019 | RARX | ↓ Sell | 10,595 | $27.77 | $294K | Direct | Aug 27, 2019 (4d) |
| Jul 15, 2019 | RARX | ↓ Sell | 10,595 | $33.10 | $351K | Direct | Jul 16, 2019 (1d) |
| Jun 17, 2019 | RARX | ↓ Sell | 10,595 | $21.84 | $231K | Direct | Jun 19, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ramin Farzaneh-Far's insider trades
Ramin Farzaneh-Far is Chief Medical Officer at Ra Pharmaceuticals (RARX). Since Jun 17, 2019, Ramin has reported no open-market purchases and 10 sales worth $4.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (11 filings), grants and awards (3 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RARX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.